June 8, 2017August 24, 2022
Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows
News
Patients with unresectable or metastatic melanoma who were treated with Keytruda (pembrolizumab) in a pivotal clinical trial showed superior and sustained time ... Read more
June 6, 2017
New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test
News
Castle Biosciences presented three abstracts on the validity of using its 31-Gene Expression Profile (GEP) Test for melanoma prognosis at the ... Read more
June 1, 2017June 2, 2017
Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer
News
Biothera Pharmaceuticals will present the detailed study design of the IMPRIME-1 clinical trial at the upcoming 2017 ASCO Annual Meeting June 2-6 in ... Read more
May 30, 2017
Researchers Provide New Insights into Melanoma Immune Resistance
News
A new study presents detailed information into the processes used by cancer cells to evade and resist the immune response. Researchers studied ... Read more
May 25, 2017May 25, 2017
New Clinical Trial Underway for Treatment of Advanced Melanoma
News
A new clinical trial is underway assessing the addition of the first-in-class AXL kinase inhibitor, BGB324, to standard of care treatment for patients with ... Read more
May 23, 2017May 23, 2017
Skin Cancer Awareness Month Brings Sun Safety to Schools
News
Educating people of all ages, particularly children, about the dangers of sun exposure is urgent to preventing the increased prevalence ... Read more
May 18, 2017
First Patient Enrolled in ONCOS-102, Keytruda Combo Trial for Advanced Melanoma
News
The first patient has been enrolled in Targovax‘s pilot clinical trial for advanced or unresectable melanoma patients whose cancer progressed after treatment ... Read more
May 16, 2017
ImmunoPulse IL-12 and Keytruda Combo Therapy to be Tested in Phase 2 Trial
News
The combination of ImmunoPulse IL-12 and the anti-PD-1 therapy Keytruda (pembrolizumab) soon will be tested in a Phase 2 trial for treatment ... Read more
May 11, 2017
Binimetinib Improves Progression-free Survival of Certain Melanoma Patients in Phase 3 Trial
News
Adding the small molecule MEK inhibitor binimetinib to the BRAF inhibitor encorafenib was safe and significantly prolonged the time to disease progression ... Read more
May 9, 2017May 9, 2017
Melanoma Scientist Among 6 in NYC Awarded Prestigious Research Prize
News
The Pershing Square Sohn Cancer Research Alliance has announced the six winners of the fourth edition of the annual Pershing ... Read more
May 4, 2017
Castle’s Gene Test Shows Accuracy in Predicting Recurrence, Spread of Head and Neck Melanoma
News
Castle Biosciences’ DecisionDx-Melanoma test can be used to accurately predict cancer recurrence and metastasis in patients with head and neck melanoma, ... Read more
April 25, 2017
IMP321, Keytruda Combo Trial Receives OK to Open Last Patient Group
News
Prima Biomed, an Australian biotechnology company developing immunotherapies for cancer and autoimmune diseases, announced it has received approval for the ... Read more

September 3, 2014September 3, 2014

Amgen Submits Marketing Authorization Application For New Melanoma Immunotherapy

Melanoma, News

Amgen, a biotechnology company developing innovative human therapeutics, has announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) seeking approval for talimogene laherparepvec as a treatment ... Read more

September 2, 2014

New Melanoma Test Improves Reliability of Melanoma Diagnosis

News

Myriad Genetics, Inc, a leading molecular diagnostic company, has presented results from its pivotal clinical validation study of the Myriad myPath™ Melanoma test at the 2014 American Society of Clinical ... Read more

August 29, 2014August 29, 2014

Macrophage Migration Inhibitory Factor Found To Be Prognostic Factor in Metastatic Melanoma

Melanoma, News

In a study entitled “Macrophage migration inhibitory factor engages PI3K/Akt signaling and is a prognostic factor in metastatic melanoma” published in the BMC Cancer journal, a group of researchers set ... Read more

August 28, 2014August 28, 2014

Water Advocate Sharon Kleyne Shares Three Rarely Reported Tips For Sun Protection

News, Skin Cancer

Hydrating before and during sun exposure, keeping sunburns moist, and learning how to recognize skin cancer: several articles have been published lately to call for awareness for simple actions that ... Read more

August 27, 2014August 27, 2014

Experimental Melanoma Drug Trains Immune System To Fight Disease

Melanoma, News

Loyola University Medical Center in Chicago is currently enrolling melanoma patients in a Phase I clinical trial for an experimental immunotherapy vaccine. The treatment will consist of ex vivo collection ... Read more

August 26, 2014August 26, 2014

Merck’s Immuno-Oncology Melanoma Drug May Be On Track For FDA Approval

Melanoma, News

Merck & Co‘s novel immuno-oncology drug for melanoma, pembrolizumab, is about to be approved by the U.S. Food and Drug Administration, according to a news report released yesterday by Reuters, ... Read more

August 25, 2014August 25, 2014

Teenagers Wear Less Sunscreen and Still Use Indoor Tanning In Spite of Skin Cancer Risks

News, Skin Cancer

Fewer teenagers wear sunscreen when exposed to the sun, and the rate of indoor tanning has hardly changed, according to a recent study conducted at William Paterson University in New Jersey and ... Read more

August 22, 2014August 22, 2014

Rare Skin Cancer that Killed Bob Marley Not Caused by UV Exposure

News, Skin Cancer

The late reggae icon Bob Marley died back in 1981, battling an uncommon type of skin cancer called acral melanoma. According to a new study by a group of investigators from the ... Read more

August 21, 2014August 21, 2014

Australian Researchers Investigate Patient, Tumor Characteristic Associations For High-Mitotic Rate Melanoma

Melanoma, News

A study by a team of Australian researchers has investigated patient and tumor characteristics for high-mitotic rate melanoma (high-mitonic is a marker of tumor cell growth) with the objective of increasing earlier ... Read more

August 20, 2014August 20, 2014

Home Care Assistance Calls For Awareness For Simple Steps That Can Prevent Skin Cancer

Skin Cancer

Staying away from tanning beds, seeking the shade whenever possible, wearing a hat, and, of course, wearing sunscreen, are four very simple steps that everyone can take to protect their ... Read more

August 18, 2014

Specialized Immune Cells That Kill Melanoma Cells Identified By Researchers

Melanoma

A team of researchers from the Walter and Eliza Hall Institute, Melbourne have found that myeloid cell leukaemia sequence-1 (Mcl1) is crucial for the survival of natural killer (NK) cells in vivo, ... Read more

August 15, 2014August 15, 2014

Breakthrough Melanoma Diagnosis Technology Could Save Patients from Unnecessary Biopsies

Melanoma, News

Just recently, Melanoma News Today reported on how a new device allowing an early non-invasive examination of melanoma and other skin cancer lesions has been developed by a team of researchers ... Read more

Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows

New Evidence Presented on Accuracy of DecisionDx-Melanoma Prognosis Test

Biothera to Present Detailed Design of Combo Therapy Study for Melanoma, Breast Cancer

Researchers Provide New Insights into Melanoma Immune Resistance

New Clinical Trial Underway for Treatment of Advanced Melanoma

Skin Cancer Awareness Month Brings Sun Safety to Schools

First Patient Enrolled in ONCOS-102, Keytruda Combo Trial for Advanced Melanoma

ImmunoPulse IL-12 and Keytruda Combo Therapy to be Tested in Phase 2 Trial

Binimetinib Improves Progression-free Survival of Certain Melanoma Patients in Phase 3 Trial

Melanoma Scientist Among 6 in NYC Awarded Prestigious Research Prize

Castle’s Gene Test Shows Accuracy in Predicting Recurrence, Spread of Head and Neck Melanoma

IMP321, Keytruda Combo Trial Receives OK to Open Last Patient Group